Literature DB >> 3088933

Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies.

A E George, M J de Leon, C I Gentes, J Miller, E London, G N Budzilovich, S Ferris, N Chase.   

Abstract

Central white matter lucencies are commonly seen in CT scans of elderly patients. Reports in the literature have implicated demyelination due to subcortical vascular disease (Binswanger disease) as the cause of these lucencies. Binswanger disease, however, is thought to be rare. Because of this apparent discrepancy we decided to determine the incidence and to attempt to define the clinical significance of the CT white-matter changes in a study population at New York University Medical Center. The studies of 275 normal and demented subjects, ages 23 to 85 years, were reviewed. All subjects received neurologic, psychiatric, and medical evaluation, formal psychometric evaluation of their cognitive status, and a CT scan. CT scans were evaluated for the presence and severity of white-matter changes (leukoencephalopathy). The incidence and severity of white-matter changes increased significantly with age (p less than 0.01). Leukoencephalopathy was consistently more common in demented patients than in normal subjects, but the difference was not statistically significant, and the severity of the leukoencephalopathy was not related to the severity of dementia (p less than 0.05). Five patients (ages 74 to 95 years) with a clinical diagnosis of Alzheimer disease who had CT evidence of lucencies were examined at autopsy. Neuropathology demonstrated extensive changes of Alzheimer disease in one brain and mild-to-moderate changes in the other four brains; areas of white-matter rarefaction were present in all brains, with microscopic evidence of arteriolar hyalinization. This study demonstrates that leukoencephalopathy is strongly related to the aging process and is seen in both "normal" and cognitively impaired individuals who have no other evidence of vascular disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3088933      PMCID: PMC8334673     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  18 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

Review 2.  Binswanger's encephalopathy: a review.

Authors:  C M Fisher
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

Review 3.  Magnetic resonance in patients with affective illness.

Authors:  W M McDonald; K R Krishnan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

4.  Carotid artery wall thickness and leukoaraiosis: preliminary results using multidetector row CT angiography.

Authors:  L Saba; L Pascalis; R Sanfilippo; M Anzidei; R Bura; R Montisci; G Mallarini
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

Review 5.  The decline and resurgence of vascular dementia.

Authors:  V C Hachinski
Journal:  CMAJ       Date:  1990-01-15       Impact factor: 8.262

6.  Xenon CT measurement of cerebral blood flow in hydrocephalus.

Authors:  P Maeder; N de Tribolet
Journal:  Childs Nerv Syst       Date:  1995-07       Impact factor: 1.475

Review 7.  Vascular dementia.

Authors:  K Amar; G Wilcock
Journal:  BMJ       Date:  1996-01-27

8.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

9.  Grading white matter lesions on CT and MRI: a simple scale.

Authors:  J C van Swieten; A Hijdra; P J Koudstaal; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

10.  Periventricular hyperintensity on magnetic resonance imaging correlated with brain ageing and atrophy.

Authors:  K Meguro; T Yamaguchi; T Hishinuma; H Miyazawa; S Ono; K Yamada; T Matsuzawa
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.